COVID-19 Impact on Imatinib Drugs Market, Global Research Reports 2020-2021
SKU ID : QYR-15705060 | Publishing Date : 25-May-2020 | No. of pages : 95
Detailed TOC of COVID-19 Impact on Imatinib Drugs Market, Global Research Reports 2020-2021
1.1 Research Scope1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Imatinib Drugs Industry
1.7 COVID-19 Impact: Imatinib Drugs Market Trends
2 Global Imatinib Drugs Quarterly Market Size Analysis
2.1 Imatinib Drugs Business Impact Assessment - COVID-19
2.1.1 Global Imatinib Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Imatinib Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Imatinib Drugs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Imatinib Drugs Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Imatinib Drugs Factory Price by Manufacturers
3.3 Location of Key Manufacturers Imatinib Drugs Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Imatinib Drugs Market
3.5 Key Manufacturers Imatinib Drugs Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Imatinib Drugs Segments, By Type
4.1 Introduction
1.4.1 Capsules
1.4.2 Tablets
4.2 By Type, Global Imatinib Drugs Market Size, 2019-2021
4.2.1 By Type, Global Imatinib Drugs Market Size by Type, 2020-2021
4.2.2 By Type, Global Imatinib Drugs Price, 2020-2021
5 Impact of Covid-19 on Imatinib Drugs Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Drug Stores
5.5.3 Other
5.2 By Application, Global Imatinib Drugs Market Size, 2019-2021
5.2.1 By Application, Global Imatinib Drugs Market Size by Application, 2019-2021
5.2.2 By Application, Global Imatinib Drugs Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Apotex Inc.
7.1.1 Apotex Inc. Business Overview
7.1.2 Apotex Inc. Imatinib Drugs Quarterly Production and Revenue, 2020
7.1.3 Apotex Inc. Imatinib Drugs Product Introduction
7.1.4 Apotex Inc. Response to COVID-19 and Related Developments
7.2 Novartis
7.2.1 Novartis Business Overview
7.2.2 Novartis Imatinib Drugs Quarterly Production and Revenue, 2020
7.2.3 Novartis Imatinib Drugs Product Introduction
7.2.4 Novartis Response to COVID-19 and Related Developments
7.3 Sanofi S.A.
7.3.1 Sanofi S.A. Business Overview
7.3.2 Sanofi S.A. Imatinib Drugs Quarterly Production and Revenue, 2020
7.3.3 Sanofi S.A. Imatinib Drugs Product Introduction
7.3.4 Sanofi S.A. Response to COVID-19 and Related Developments
7.4 Cipla Inc.
7.4.1 Cipla Inc. Business Overview
7.4.2 Cipla Inc. Imatinib Drugs Quarterly Production and Revenue, 2020
7.4.3 Cipla Inc. Imatinib Drugs Product Introduction
7.4.4 Cipla Inc. Response to COVID-19 and Related Developments
7.5 Mylan Pharms Inc.
7.5.1 Mylan Pharms Inc. Business Overview
7.5.2 Mylan Pharms Inc. Imatinib Drugs Quarterly Production and Revenue, 2020
7.5.3 Mylan Pharms Inc. Imatinib Drugs Product Introduction
7.5.4 Mylan Pharms Inc. Response to COVID-19 and Related Developments
7.6 Glenmark Pharmaceuticals Ltd.
7.6.1 Glenmark Pharmaceuticals Ltd. Business Overview
7.6.2 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Quarterly Production and Revenue, 2020
7.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Introduction
7.6.4 Glenmark Pharmaceuticals Ltd. Response to COVID-19 and Related Developments
7.7 Sun Pharmaceuticals
7.7.1 Sun Pharmaceuticals Business Overview
7.7.2 Sun Pharmaceuticals Imatinib Drugs Quarterly Production and Revenue, 2020
7.7.3 Sun Pharmaceuticals Imatinib Drugs Product Introduction
7.7.4 Sun Pharmaceuticals Response to COVID-19 and Related Developments
7.8 Actavis Generics
7.8.1 Actavis Generics Business Overview
7.8.2 Actavis Generics Imatinib Drugs Quarterly Production and Revenue, 2020
7.8.3 Actavis Generics Imatinib Drugs Product Introduction
7.8.4 Actavis Generics Response to COVID-19 and Related Developments
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Business Overview
7.9.2 Dr. Reddy's Laboratories Imatinib Drugs Quarterly Production and Revenue, 2020
7.9.3 Dr. Reddy's Laboratories Imatinib Drugs Product Introduction
7.9.4 Dr. Reddy's Laboratories Response to COVID-19 and Related Developments
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Teva Pharmaceutical Industries Ltd. Business Overview
7.10.2 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Quarterly Production and Revenue, 2020
7.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Introduction
7.10.4 Teva Pharmaceutical Industries Ltd. Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Imatinib Drugs Supply Chain Analysis
8.1.1 Imatinib Drugs Supply Chain Analysis
8.1.2 Covid-19 Impact on Imatinib Drugs Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Imatinib Drugs Distribution Channels
8.2.2 Covid-19 Impact on Imatinib Drugs Distribution Channels
8.2.3 Imatinib Drugs Distributors
8.3 Imatinib Drugs Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of Figures, Tables and Charts Available in COVID-19 Impact on Imatinib Drugs Market, Global Research Reports 2020-2021
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Imatinib Drugs Assessment
Table 9. COVID-19 Impact: Imatinib Drugs Market Trends
Table 10. COVID-19 Impact Global Imatinib Drugs Market Size
Table 11. Global Imatinib Drugs Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Imatinib Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Imatinib Drugs Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Imatinib Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Imatinib Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Imatinib Drugs Market Growth Drivers
Table 17. Global Imatinib Drugs Market Restraints
Table 18. Global Imatinib Drugs Market Opportunities
Table 19. Global Imatinib Drugs Market Challenges
Table 20. Key Manufacturers Imatinib Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Imatinib Drugs Market Size, 2019 (K MT) & (US$ Million)
Table 22. Imatinib Drugs Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Imatinib Drugs Manufacturing Plants
Table 24. Key Manufacturers Imatinib Drugs Market Served
Table 25. Date of Key Manufacturers Enter into Imatinib Drugs Market
Table 26. Key Manufacturers Imatinib Drugs Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Imatinib Drugs Market Size by Type, 2020, (US$ Million)
Table 29. Global Imatinib Drugs Market Size by Type, 2020 (K MT)
Table 30. Global Imatinib Drugs Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Imatinib Drugs Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Imatinib Drugs Market Size by Application, 2020-2021 (K MT)
Table 33. Global Imatinib Drugs Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Imatinib Drugs Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Imatinib Drugs Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Imatinib Drugs Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Imatinib Drugs Market Size, 2019-2021 (K MT)
Table 38. US Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Imatinib Drugs Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Imatinib Drugs Market Size, 2019-2021 (K MT)
Table 43. Germany Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Imatinib Drugs Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Imatinib Drugs Market Size, 2019-2021 (K MT)
Table 50. China Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Imatinib Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. Apotex Inc. Business Overview
Table 58. Apotex Inc. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Apotex Inc. Imatinib Drugs Product
Table 60. Apotex Inc. Response to COVID-19 and Related Developments
Table 61. Novartis Business Overview
Table 62. Novartis Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis Imatinib Drugs Product
Table 64. Novartis Response to COVID-19 and Related Developments
Table 65. Sanofi S.A. Business Overview
Table 66. Sanofi S.A. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Sanofi S.A. Imatinib Drugs Product
Table 68. Sanofi S.A. Response to COVID-19 and Related Developments
Table 69. Cipla Inc. Business Overview
Table 70. Cipla Inc. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Cipla Inc. Imatinib Drugs Product
Table 72. Cipla Inc. Response to COVID-19 and Related Developments
Table 73. Mylan Pharms Inc. Business Overview
Table 74. Mylan Pharms Inc. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Mylan Pharms Inc. Imatinib Drugs Product
Table 76. Mylan Pharms Inc. Response to COVID-19 and Related Developments
Table 77. Glenmark Pharmaceuticals Ltd. Business Overview
Table 78. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product
Table 80. Glenmark Pharmaceuticals Ltd. Response to COVID-19 and Related Developments
Table 81. Sun Pharmaceuticals Business Overview
Table 82. Sun Pharmaceuticals Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Sun Pharmaceuticals Imatinib Drugs Product
Table 84. Sun Pharmaceuticals Response to COVID-19 and Related Developments
Table 85. Actavis Generics Business Overview
Table 86. Actavis Generics Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Actavis Generics Imatinib Drugs Product
Table 88. Actavis Generics Response to COVID-19 and Related Developments
Table 89. Dr. Reddy's Laboratories Business Overview
Table 90. Dr. Reddy's Laboratories Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Dr. Reddy's Laboratories Imatinib Drugs Product
Table 92. Dr. Reddy's Laboratories Response to COVID-19 and Related Developments
Table 93. Teva Pharmaceutical Industries Ltd. Business Overview
Table 94. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product
Table 96. Teva Pharmaceutical Industries Ltd. Response to COVID-19 and Related Developments
Table 97. Imatinib Drugs Distributors List
Table 98. Imatinib Drugs Customers List
Table 99. Covid-19 Impact on Imatinib Drugs Customers
List of Figures
Figure 1. Imatinib Drugs Product Picture
Figure 2. Imatinib Drugs Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Imatinib Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Imatinib Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Imatinib Drugs Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Imatinib Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Imatinib Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Imatinib Drugs Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Imatinib Drugs Market Size Market Share, 2019-2021
Keyplayers in COVID-19 Impact on Imatinib Drugs Market, Global Research Reports 2020-2021
Apotex Inc.Novartis
Sanofi S.A.
Cipla Inc.
Mylan Pharms Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.